Skip to main content
. 2022 Nov 15;41(4):816–825. doi: 10.1200/JCO.22.00575

FIG A1.

FIG A1.

Time to treatment failure on the basis of independent central review (full analysis set). Two patients were excluded from cohort 2 because they had no HER2 status result in central laboratory assessment. HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; ISH, in situ hybridization.